Product logins

Find logins to all Clarivate products below.


Structural Heart Closure Devices – Market Insights – Asia Pacific

Although the global COVID-19 pandemic negatively impacted the Asia Pacific structural heart closure device market in 2020, strong prepandemic growth trends in the PFO and LAA segments helped to sustain positive overall procedure volume and market growth for the year, and the market has subsequently shown strong recovery. Going forward, the market will continue to expand through 2032, supported by continued robust growth in the well-established Australian market, expanding evidence demonstrating the safety and efficacy of transcatheter and epicardial structural heart closure procedures, the introduction of new devices, and growing competition from and the strong presence of domestic manufacturers offering low-cost products in the large and expanding Chinese market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the structural heart closure device market in Asia Pacific from 2019 through 2032.

The Asia Pacific structural heart closure device market will be impacted by the COVID-19 pandemic in the early years of the forecast period.

How did the COVID-19 pandemic impact the global structural heart closure device, and to what extent has it recovered?

When is the structural heart closure market expected to revert to pre-pandemic growth?

The Asia Pacific market for structural heart closure devices will grow moderately through 2032.

What are upcoming developments in the structural heart closure device market?

What ongoing clinical trials will impact the structural heart closure device market?

How are clinical developments across the globe impacting the Asia Pacific structural heart closure device market?

Which new devices have been launched over the past year and are expected to launch in the Asia Pacific market?

The LAA closure device segment represents a significant market opportunity for manufacturers in the structural heart closure device space.

What strategies will MNCs adopt to compete with the domestic players in the Asia Pacific market?

Who are the new players in the LAA closure device market?

How are the domestic players able to maintain their position in the Asia Pacific market?

Table of contents


Related Medtech Insights Reports

Report
Vascular Closure Devices – Market Insights – Global
The global VCD market will grow moderately, driven primarily by increasing endovascular interventional procedure volumes and by innovation associated with new products entering the market. Growth…
Report
Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and…
Report
Cardiac Rhythm Management Devices – Market Insights – United States
The US CRM device market is expected to grow rapidly through 2034, driven by the increasing adoption of innovative devices, such as dual-chamber leadless pacemakers and extravascular ICDs. These…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…